Insightful, customized solutions for innovative business leaders
In today’s fast-paced marketplace and complicated regulatory environment, operating in the life sciences industry can bring a variety of challenges. From raising and managing capital to protecting intellectual property and prioritizing research and development efforts, you require business advisors who understand your complex issues and the speciﬁc business problems you might face.
This recent interview with Risk & Compliance magazine discusses the unique bribery and corruption risks life sciences organizations face.
A recent opinion by the Advocate General (AG) for the European Court of Justice (ECJ) opens the door for pharmaceutical companies to potentially claw back previously charged value added tax (VAT).
A white paper about how entities in the life sciences industry may be affected by the new revenue recognition guidance in ASC 606.
Learn what the board and others who have executive oversight of life sciences companies need to understand about minimizing corruption risk.
Resources to help you gain an understanding of the eligibility criteria and re-examine your eligibility for the R&D credit.
California biotech firm sees larger corporate tax bill after Massachusetts high court determination that it was engaged in manufacturing.
Learn about improvements to the share-based compensation standard and its impact on the life sciences industry.
Learn how growing life sciences companies leverage finance and accounting outsourcing to enhance the finance function and focus on core competencies.
While large public company inversions have received the press coverage, middle market and private companies can invert and achieve similar benefits.
Commercializing new drugs is more challenging than ever, but increasing focus on your finance function can better manage a difficult business model.
Contact Our Team
National Practice Leader